fr
Gustave Roussy 114, rue Édouard-Vaillant 94805 Villejuif Cedex - France Switchboard:
+33 (0)1 42 11 42 11
GUSTAVE ROUSSY 1st cancer center in Europe
© 2006-2015 Gustave Roussy – All rights reserved
Professor Fabrice Barlesi is one of the key figures in the “MAKE IT ICONIC. Choose France” campaign, which promotes French audacity and innovation on a global scale.
For the fifth consecutive year, Newsweek magazine has ranked Gustave Roussy among the top five hospitals for oncology worldwide, highlighting its outstanding performance in both patient care and research.
Bringing together more than 31,000 international experts, the European Society of Medical Oncology (ESMO) annual congress is one of the highlights of global oncology. This year, it will be held from 13 to 17 September in Barcelona. Gustave Roussy, the leading cancer research and treatment centre in France and Europe, ranked fourth globally, is one...
From 31 May to 4 June, ASCO, the world’s largest cancer conference, is held in Chicago, USA. This year, Gustave Roussy’s physician-researchers participated in more than 130 abstracts selected by the conference’s scientific committee, testifying to the quality of the research conducted at the Institute, and its impact on a global scale.
The third edition of the Transatlantic Exchanges will be held in Boston on April 12th, 2024. Broadcast online live, this day of exchanges is an opportunity to follow high-level debates on the perspectives opened by liquid biopsy in precision oncology.
Le congrès ESMO Targeted Anticancer Therapies (TAT), organisé annuellement en Europe depuis 2018, est un événement incontournable dans le champ des nouvelles cibles et des nouveaux agents anticancéreux prometteurs, notamment ceux en essais précoces de développement clinique.
The ARC Foundation, which has joined forces with four European cancer charities under the ATTRACT grant, awards funding to the FOSTER-CabOS project. The grant obtained through this call for projects will fund a European Phase III clinical trial to evaluate cabozantinib, a tyrosine kinase inhibitor, to treat osteosarcoma, a rare type cancer.
The annual congress of the European Society of Medical Oncology (ESMO) will be held in Madrid from October 20 to 24, 2023. This key event in the world of oncology presents the main advances in clinical research. Gustave Roussy is one of the major players.
Acclaimed by its peers the world over, Gustave Roussy is once again among the world's top 5 cancer institutes, in 4th place in the ranking of cancer hospitals published by the American magazine Newsweek for the year 2024. This position, after three of the most prestigious American centers, positions Gustave Roussy as a world leader in oncology,...
The largest international oncology congress, the American Society of Clinical Oncology (ASCO), will be held in Chicago, United States, from June 2nd to 6th, 2023. Gustave Roussy will once again be present with nearly fifty presentations. Deciphering these studies that bring new therapeutic strategies for the benefit of patients.